Literature DB >> 1730503

Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development.

D L Doolan1, A J Saul, M F Good.   

Abstract

The design of a subunit vaccine against the malaria parasite relies on the epitopes recognized by T cells being identified and polymorphisms therein being defined. Here we present the analysis of a 354-bp fragment of the circumsporozoite (CS) protein encompassing defined proliferative and cytotoxic T-cell recognition regions. We reveal that the polymorphism of CS protein T-cell sites appears to be very limited among Plasmodium falciparum isolates prevalent in certain geographical regions, in particular Papua New Guinea. Furthermore, the more extensive polymorphism noted in other areas appears to be restricted. Although the extent of variation observed for the T-cell recognition domains suggests that any vaccine designed to stimulate this form of immunity will need to be polyvalent, this variation appears to be finite and the combination of peptides necessary for inclusion in a polyvalent vaccine may be small. If ways to increase immune responsiveness can be found, then a vaccine designed to stimulate CS protein-specific T-cell activity may prevent malaria.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730503      PMCID: PMC257683          DOI: 10.1128/iai.60.2.675-682.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Major population differences in T cell response to a malaria sporozoite vaccine candidate.

Authors:  Y Zevering; R A Houghten; I H Frazer; M F Good
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

2.  Variation in the precursor to the major merozoite surface antigens of Plasmodium falciparum.

Authors:  M G Peterson; R L Coppel; P McIntyre; C J Langford; G Woodrow; G V Brown; R F Anders; D J Kemp
Journal:  Mol Biochem Parasitol       Date:  1988-01-15       Impact factor: 1.759

3.  The circumsporozoite protein gene from NF54, a Plasmodium falciparum isolate used in malaria vaccine trials.

Authors:  P Caspers; R Gentz; H Matile; J R Pink; F Sinigaglia
Journal:  Mol Biochem Parasitol       Date:  1989-06-15       Impact factor: 1.759

4.  7H8/6, a multicopy DNA probe for distinguishing isolates of Plasmodium falciparum.

Authors:  T Limpaiboon; M W Shirley; D J Kemp; A Saul
Journal:  Mol Biochem Parasitol       Date:  1991-08       Impact factor: 1.759

5.  Plasmodium falciparum: restricted polymorphism of T cell epitopes of the circumsporozoite protein in Brazil.

Authors:  N Yoshida; S M Di Santi; A P Dutra; R S Nussenzweig; V Nussenzweig; V Enea
Journal:  Exp Parasitol       Date:  1990-11       Impact factor: 2.011

6.  CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.

Authors:  M M Rodrigues; A S Cordey; G Arreaza; G Corradin; P Romero; J L Maryanski; R S Nussenzweig; F Zavala
Journal:  Int Immunol       Date:  1991-06       Impact factor: 4.823

7.  Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein.

Authors:  A Malik; J E Egan; R A Houghten; J C Sadoff; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

8.  Mutations with multiple independent origins in surface antigens mark the targets of biological selective pressure.

Authors:  T F McCutchan; A P Waters
Journal:  Immunol Lett       Date:  1990-08       Impact factor: 3.685

9.  Genetic analysis of the human malaria parasite Plasmodium falciparum.

Authors:  D Walliker; I A Quakyi; T E Wellems; T F McCutchan; A Szarfman; W T London; L M Corcoran; T R Burkot; R Carter
Journal:  Science       Date:  1987-06-26       Impact factor: 47.728

10.  The immunologic significance of variation within malaria circumsporozoite protein sequences.

Authors:  V F De La Cruz; W L Maloy; L H Miller; M F Good; T F McCutchan
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

View more
  16 in total

1.  The cytotoxic T-lymphocyte epitope of the Plasmodium falciparum circumsporozoite protein also modulates the efficiency of receptor-ligand interaction with hepatocytes.

Authors:  D Rathore; T F McCutchan
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids.

Authors:  R Wang; D L Doolan; Y Charoenvit; R C Hedstrom; M J Gardner; P Hobart; J Tine; M Sedegah; V Fallarme; J B Sacci; M Kaur; D M Klinman; S L Hoffman; W R Weiss
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 3.  Class I HLA-restricted cytotoxic T lymphocyte responses against malaria--elucidation on the basis of HLA peptide binding motifs.

Authors:  D L Doolan; B Wizel; S L Hoffman
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 4.  Plasmodium immunomics.

Authors:  Denise L Doolan
Journal:  Int J Parasitol       Date:  2010-09-16       Impact factor: 3.981

5.  Sequence variation in the T-cell epitopes of the Plasmodium falciparum circumsporozoite protein among field isolates is temporally stable: a 5-year longitudinal study in southern Vietnam.

Authors:  Amadu Jalloh; Huynh van Thien; Marcelo U Ferreira; Jun Ohashi; Hiroyuki Matsuoka; Toshio Kanbe; Akihiko Kikuchi; Fumihiko Kawamoto
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

Review 6.  Genetic analysis of host-parasite coevolution in human malaria.

Authors:  A V Hill; A Jepson; M Plebanski; S C Gilbert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

Review 7.  The optimization of helper T lymphocyte (HTL) function in vaccine development.

Authors:  J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

Review 8.  Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

Authors:  S L Takala; C V Plowe
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

9.  Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.

Authors:  John N Waitumbi; Samuel B Anyona; Carol W Hunja; Carolyne M Kifude; Mark E Polhemus; Douglas S Walsh; Chris F Ockenhouse; D Gray Heppner; Amanda Leach; Marc Lievens; W Ripley Ballou; Joe D Cohen; Colin J Sutherland
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

10.  Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.

Authors:  Mohammad Zeeshan; Mohammad Tauqeer Alam; Sumiti Vinayak; Hema Bora; Rupesh Kumar Tyagi; Mohd Shoeb Alam; Vandana Choudhary; Pooja Mittra; Vanshika Lumb; Praveen Kumar Bharti; Venkatachalam Udhayakumar; Neeru Singh; Vidhan Jain; Pushpendra Pal Singh; Yagya Dutta Sharma
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.